News: Biologics, Therapeutics and Devices

Inside the "biological foundry" at the Army Research Lab's ARL-South partnership on the campus of UT Austin

Jason McLellan, UT Austin molecular biosciences professor, has received the 2021 Shirley Bird Perry Longhorn Citizenship Award

For his role in biomedical research linked to the development of vaccines and treatments for COVID-19, the professor of molecular biosciences won the award given...

Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD

A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.

The world’s largest multidisciplinary scientific society has announced that Jason McLellan, a University of Texas at Austin associate professor in the Department of Molecular Biosciences...

The virus that causes COVID-19 is accumulating genetic mutations, one of which may have made it more contagious.

A redesigned version of the coronavirus spike protein called HexaPro might speed up vaccine production and yield a more effective immune response to SARS-CoV-2.

The hunt for an effective treatment for COVID-19 has led researchers to find an improbable ally for their work: a llama named Winter.

Genetically engineered strains of bacteria protect bees from mites and viruses that can lead to colony collapse.